Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Preveceutical Medical Inc PRVCF


Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based... see more

Recent & Breaking News (CSE:PREV)

IIROC Trading Halt - PREV

Canada NewsWire August 4, 2020

PreveCeutical Announces Appointment of Director and Public Officer

Newsfile July 30, 2020

PreveCeutical Approaches Completion of Non-Addictive Analgesic Program

Newsfile July 21, 2020

PreveCeutical Announces Advance in the Formulation and Biological Delivery of Therapy for Diabetes and Obesity

Newsfile July 15, 2020

PreveCeutical Confirms Receipt of CBD For Sol-Gel

Newsfile July 13, 2020

PreveCeutical Announces Filing of Provisional Patent Application

Newsfile July 8, 2020

PreveCeutical Announces Stability Data from CBD Sol-gel Product Development Program

Newsfile July 6, 2020

PreveCeutical Announces Promising 3D Liver Tissue Testing of Potential Therapy for Diabetes and Obesity

Newsfile June 29, 2020

IIROC Trade Resumption - PREV

Canada NewsWire June 22, 2020

PreveCeutical Executes Agreement for Development of CBD Sol-Gel Nasal Spray Formulation as a Potential Treatment for SARS-CoV-2 Infection

Newsfile June 22, 2020

IIROC Trading Halt - PREV

Canada NewsWire June 22, 2020

PreveCeutical Announces Sol-Gel Chemistry Fingerprinting SOPs

Newsfile June 17, 2020

PreveCeutical Issued Statement Regarding Promotional Activity

Newsfile June 16, 2020

PreveCeutical Announces Further Successful Results from The Sol-Gel Program Final Report

Newsfile June 15, 2020

PreveCeutical Announces Certain Warrants Expiring on June 29, 2020

Newsfile June 8, 2020

PreveCeutical Announces Successful Completion of its Sol-gel Program

Newsfile June 3, 2020

PreveCeutical Applies for Viral Prevention Program Funding

Newsfile June 1, 2020

PreveCeutical Announces Debt Settlement and Conversion of Debt

Newsfile May 22, 2020

IIROC Trade Resumption - PREV

Canada NewsWire May 4, 2020

PreveCeutical Announces Possible Viral Prevention Program Using CBD Sol-gel

Newsfile May 4, 2020